QSAR MODELING OF 2-[CH(OH)X]-5,8-(OY)2 -1,4-NAPHTHOQUININES AGAINST L1210 CELLS USING MULTIPLE LINEAR REGRESSION
Abstract
Quinones are present in many drugs such as anthracyclines, daunorubicin, doxorubicin, mitomycin, mitoxantrones and saintopin, which are used clinically in the therapy of solid cancers. The cytotoxic effects of these quinone are mainly due to the inhibition of DNA topoisomerase-II. It is the necessity to develop the 1,4-Naphthoquinone analogues with Cytotoxic effect. Here 2-[CH(OH)X]-5,8-(OY)2-1,4-Naphthoquinines analogues have been used to correlate the cytotoxic activity with the Eccentric Connectivity index (ECI), Fragment Complexity (FC) and McGowan Volumes (MG) for studying the Quantitative Structure Activity Relationship (QSAR). Correlation may be an adequate predictive model which can help to provide guidance in designing and subsequently yielding greatly specific compounds that may have reduced side effects and improved pharmacological activities. We have used Multiple Linear Regression (MLR), one of the best methods for developing the QSAR model. Results from this QSAR study have suggested that ECI, FC and MG are the important descriptors for cytotoxic activities of 1,4-Naphthoquinones against L1210 cells. For the validation of the developed QSAR model, statistical analysis such as data point-descriptor ratio, fraction of variance, cross validation test, standard deviation, quality factor, Fischer’s test; and internal validation such as Y-randomization test have been performed and all the tests validated this QSAR model.
Key words: 1,4-Naphthoquinones, QSAR, Eccentric connectivity index, Fragment complexity, McGowan Volume, Multiple Linear Regression
Full Text:
UntitledReferences
Ajeet, 2012, QSAR modeling of recombinant human stromelysin inhibitors– MLR approach, Int. J. Adv. Pharm. Biol. Sci, 2(2), 171-175
Ajeet, Kumar, Vipul, Singh, and Brajpal, 2012, QSAR modeling of gelatinase inhibitors: MLR approach, Int. Res. J. Pharm., 3(3), 216-218
Arcamone, F., Cassinelli, G., 1998, Biosynthetic anthracyclines, Curr. Med. Chem., 5, 391–419
Begleiter, A., 2000, Clinical applications of quinone-containing alkylating agents, Front. Biosci., 5, E153–E171
Abhishek C., Dey, Pradip, Sen, Shantanu, Chetia, Pankaj, Choudhury Manabendra, Dutta, Dutta, Sharma G., 2012, An in silico appraisal of few bioactive compounds against kas-a for antitubercular drug efficacy, Asian. J. Pharm. Clin. Res., 5(1), 60-62
Di Marco, A., Cassinelli, G., Arcamone, and F., 1981, The discovery of daunorubicin, Cancer. Treat. Rep., 65, 3–8
Gregg, Siegal, and Eiso, A., B., 2007, Jan Schultz. Integration of fragment screening and library design, Drug Discovery Today, 12(23/24), 1032-1039
Lee, K. H., 1999, Novel antitumor agents from higher plants, Med. Res. Rev., 19, 569–596
Martyn, T., and Smith, 1985, Quinones as mutagens, carcinogens, and anticancer agents: Introduction and overview, J. Tox. Envir. Health., 16(5), DOI:10.1080/1528739850 9530776
McIntire, W. S., 1998, Newly discovered redox cofactors: possible nutritional, medical and pharmacological relevance to higher animals, Ann. Rev. Nutr., 18, 145–177
Meganathan, R., 2001, Biosynthesis of menaquinone (vitamin K2) and ubiquinone (coenzyme Q): a perspective on enzymatic mechanisms, Vitam. Horm., 61, 173–218
Michael, H., Abraham, , Ibrahim A., and Andreas, M., Zissimos, 2004, Determination of sets of solute descriptors from chromatographic measurements, J. Chromatography, 1037, 29–47
Rajeshwar, P., Verma, 2006, Anti-Cancer Activities of 1,4-Naphthoquinones: A QSAR Study, Anti-Cancer Agents in Medicinal Chemistry, 6, 489-499
Sahu, Satish, Kohli, D., V., 2012, Banerjee Lopamudra 3D-QSAR Studies of Some Thiazolidinesdiones as Peroxisome Proliferator Activated Receptor (PPARγ) Agonist, Int. J. Pharm. Pharm. Sci., 4(1), 148-153
Sardana, S., and Madan, A., K., 2003, Topological models for prediction of antihypertensive activity of substituted benzylimidazoles, J. Mol. Struct. (Theochem), 638, 41-49
Sharma, Brij, Kishore, Singh, Prithvi, Sarbhai, Kirti, 2009, A QSAR Study on 5-HT7 Receptor Antagonists: Derivatives of (Phenylpiperazinyl-Alkyl) Oxindole, Int. J. Pharm. Pharm. Sc.i 1(1), 227-239
Verma, Rajeshwar, P., and Hansch, Corwin, 2010, QSAR modeling of taxane analogues against colon cancer, Eur. J. Med. Chem. 45, 1470-1477
Yap, C., W., 2011, PaDEL-descriptor: open source software to calculate molecular descriptors and fingerprints, J. Comput. Chem., 32(7), 1466-1474
DOI: http://dx.doi.org/10.14499/indonesianjpharm23iss3pp171-176
Refbacks
- There are currently no refbacks.
Copyright (c) 2017 INDONESIAN JOURNAL OF PHARMACY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Indonesian J Pharm indexed by:
View My Stats